Breakthrough! China approved 76 new innovative drugs last year, with foreign authorization exceeding 100 billion US dollars.

Today, it was learned from the National Medical Products Administration that in 2025, China has approved a total of 76 innovative drugs for market launch, significantly exceeding the 48 approved in the entire year of 2024, reaching a historical high. In addition, in 2025, the total amount of foreign authorized transactions for innovative drugs in China exceeded 130 billion US dollars, with over 150 authorized transactions, also setting a historical record.